MIH
DGX icon

Meitav Investment House’s Quest Diagnostics DGX Stock Holding History

Meitav Investment House’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,719
Closed -$374K – 451
2019
Q2 		$374K Buy
+3,719
New +$357K 0.02% 287

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Meitav Investment House's DGX Position: Q3 2019 in Review

Meitav Investment House sold out of Quest Diagnostics (DGX) in Q3 2019, closing a stake of 3,719 shares — an estimated $374K sold.

Meitav Investment House first reported a position in DGX in Q2 2019 and held it in 1 quarter. The position peaked at $374K in Q2 2019. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Meitav Investment House reported no remaining Quest Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Meitav Investment House sold 3,719 Quest Diagnostics shares in Q3 2019, an estimated $374K.
  • Meitav Investment House first reported a position in Quest Diagnostics in Q2 2019 and held it in 1 quarter.
  • Meitav Investment House's Quest Diagnostics position peaked at $374K in Q2 2019.
  • 676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Meitav Investment House's 13F filing for Q3 2019, filed 14 Nov 2019.